Who are Group III - Serratiopeptidase Group's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/group-iii-serratiopeptidase-group.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Group III - Serratiopeptidase Group — Competitive Intelligence Brief

Group III - Serratiopeptidase Group (Group III - Serratiopeptidase Group) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Serine protease enzyme. Area: Inflammation, Pain Management, Orthopedics.

phase 3 Serine protease enzyme Non-structural proteins, fibrin, inflammatory mediators Inflammation, Pain Management, Orthopedics Small molecule Live · refreshed every 30 min

Target snapshot

Group III - Serratiopeptidase Group (Group III - Serratiopeptidase Group) — Zahoor khan. Serratiopeptidase is a serine protease enzyme that breaks down non-structural proteins and fibrin, reducing inflammation and promoting tissue repair.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Group III - Serratiopeptidase Group TARGET	Group III - Serratiopeptidase Group	Zahoor khan	phase 3	Serine protease enzyme	Non-structural proteins, fibrin, inflammatory mediators

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Serine protease enzyme class)

Zahoor khan · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Group III - Serratiopeptidase Group — Competitive Intelligence Brief. https://druglandscape.com/ci/group-iii-serratiopeptidase-group. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab